Candidate multi-peptide-vaccine against classical swine fever virus induced potent immunity with serological marker

被引：23

作者：

Dong, XN ^{[1
]}

Chen, Y ^{[1
]}

Wu, Y ^{[1
]}

Chen, YH ^{[1
]}

机构：

[1] Tsing Hua Univ, Dept Biol, Immunol Lab, Prot Sci Lab MOE, Beijing 100084, Peoples R China

来源：

VACCINE | 2005年 / 23卷 / 28期

关键词：

classical swine fever virus (CSFV); multi-peptide-vaccine (MPV); marker vaccines; aluminum adjuvant;

D O I：

10.1016/j.vaccine.2005.02.008

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Our previous study proposed a protective multi-peptide-vaccine (MPV) with Freund's adjuvant against classical swine fever virus (CSFV). In this study, another candidate MPV, using aluminum adjuvant, was further examined. All immunized pigs kept healthy during the experimental period, while the control group rapidly showed clinical symptoms and died. Moreover. anti-sera from MPV-immunized pigs could interact with peptides involved in the MPV. in contrast to anti-sera from non-immunized or infected ones, This property permits MPV-immunized pigs to be easily differentiated from infected ones with simple serological method. Therefore, this new MPV is suitable to act as a candidate marker vaccine against CSFV. © 2005 Elsevier Ltd. All rights reserved.

引用

页码：3630 / 3633

页数：4

共 50 条

[21] A Promising Trigene Recombinant Human Adenovirus Vaccine Against Classical Swine Fever Virus
Li, Helin
Gao, Rui
Zhang, Yanming
VIRAL IMMUNOLOGY, 2016, 29 (04) : 244 - 251
[22] Head Start Immunity: Characterizing the Early Protection of C Strain Vaccine Against Subsequent Classical Swine Fever Virus Infection
McCarthy, Ronan R.
Everett, Helen E.
Graham, Simon P.
Steinbach, Falko
Crooke, Helen R.
FRONTIERS IN IMMUNOLOGY, 2019, 10
[23] Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunity
Gabriel, Claudia
Blome, Sandra
Urniza, Alicia
Juanola, Sandra
Koenen, Frank
Beer, Martin
VACCINE, 2012, 30 (19) : 2928 - 2936
[24] Porvac® Subunit Vaccine Protects Against Three Field Isolates of Classical Swine Fever Virus
Sordo-Puga, Yusmel
Rodriguez-Molto, Maria Pilar
Perez-Perez, Danny
Naranjo-Valdes, Paula
Sardina-Gonzalez, Talia
Mendez-Orta, Mary Karla
Santana-Rodriguez, Elaine
Vargas-Hernandez, Milagros
Laura Perera, Carmen
Duarte, Carlos A.
Suarez-Pedroso, Marisela
VACCINES, 2025, 13 (02)
[25] Assessment of the Safety Profile of Chimeric Marker Vaccine against Classical Swine Fever: Reversion to Virulence Study
Huynh, Loc Tan
Otsuka, Mikihiro
Kobayashi, Maya
Ngo, Hung Dinh
Hew, Lim Yik
Hiono, Takahiro
Isoda, Norikazu
Sakoda, Yoshihiro
VIRUSES-BASEL, 2024, 16 (07):
[26] An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV)
van Rijn, PA
van Gennip, HGP
Moormann, RJM
VACCINE, 1999, 17 (05) : 433 - 440
[27] Quadruple antigenic epitope peptide producing immune protection against classical swine fever virus
Liu, Siguo
Yu, Xinglong
Wang, Chunlai
Wu, Jianmin
Kong, Xiangang
Tu, Changchun
VACCINE, 2006, 24 (49-50) : 7175 - 7180
[28] Pre-registration efficacy studies of a novel marker vaccine against classical swine fever on target animals
Levai Reka
Barna Timea
Fabian Katalin
Sandra Blome
Belak Katinka
Balint Adam
Frank Koenen
Kulcsar Gabor
Farsang Attila
MAGYAR ALLATORVOSOK LAPJA, 2019, 141 (04) : 227 - 243
[29] African swine fever virus proteins against host antiviral innate immunity and their implications for vaccine development
Orosco, Fredmoore L.
OPEN VETERINARY JOURNAL, 2024, 14 (04) : 941 - 951
[30] Classical swine fever virus replicon particles lacking the Erns gene:: a potential marker vaccine for intradermal application
Frey, Caroline F.
Bauhofer, Oliver
Ruggli, Nicolas
Summerfield, Artur
Hofmann, Martin A.
Tratschin, Jon-Duri
VETERINARY RESEARCH, 2006, 37 (05) : 655 - 670

← 1 2 3 4 5 →